SonoThera (Series B)
Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
January 8, 2026
Vertical
Biotechnology
Funding Amount
$125,000,000
Company Info
Market
Genetic Medicines
Location
South San Francisco, California, USA
Company Description

SonoThera™ is a biotechnology company dedicated to treating the root cause of human diseases through developing the next generation of genetic medicines. Our nonviral technology is designed to overcome all prevailing limitations of genetic medicine, enabling a pipeline of products which leverages our novel capabilities.

Links